Home Immunization with Palivizumab-A Randomized Pilot Study Describing Safety Aspects and Parents' Preferences
Among prematurely born infants and newborns with chronic conditions, a respiratory syncytial virus (RSV) infection may cause (re-)admission and later respiratory complications. Therapeutic protection is possible with monthly injections of a specific monoclonal antibody, palivizumab, during RSV seaso...
Saved in:
Main Authors: | Christina Ebersjö (Author), Eva Berggren Broström (Author), Inger Kull (Author), Anna Lindholm Olinder (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral health problems linked to obstructive sleep apnea are not always recognized within dental care-As described by dental professionals
by: Kristina Berggren, et al.
Published: (2022) -
Effect of an In-Home Palivizumab Administration Program for Children with Medical Complexity
by: Hina Emanuel, et al.
Published: (2024) -
PALIVIZUMAB: NEW OPPORTUNITIES FOR THE ASTHMA PREVENTION?
by: E.A. Vishneva, et al.
Published: (2011) -
PALIVIZUMAB: NEW OPPORTUNITIES FOR THE ASTHMA PREVENTION?
by: E.A. Vishneva, et al.
Published: (2011) -
Palivizumab prophylaxis of RSV infections in Bosnia and Herzegovina
by: Suada Heljic, et al.
Published: (2016)